(NYSE: AORT) Artivion's forecast annual revenue growth rate of 10.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Artivion's revenue in 2026 is $458,689,000.On average, 10 Wall Street analysts forecast AORT's revenue for 2026 to be $24,127,501,251, with the lowest AORT revenue forecast at $22,834,791,840, and the highest AORT revenue forecast at $25,230,406,163. On average, 10 Wall Street analysts forecast AORT's revenue for 2027 to be $26,798,841,801, with the lowest AORT revenue forecast at $24,961,476,004, and the highest AORT revenue forecast at $28,298,831,316.
In 2028, AORT is forecast to generate $29,769,694,821 in revenue, with the lowest revenue forecast at $27,668,253,200 and the highest revenue forecast at $31,777,447,777.